Zydus had approached the Supreme Court challenging the Delhi High Court’s order, which prevented the company from producing and marketing breast cancer drug Sigrima.
Zydus had approached the Supreme Court challenging the Delhi High Court’s order, which prevented the company from producing and marketing breast cancer drug Sigrima.